testosterone undecanoate has been researched along with Innate Inflammatory Response in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bañuls, C; Gómez-Balaguer, M; Hurtado-Murillo, F; Iannantuoni, F; López-Domènech, S; Martinez de Marañon, A; Morillas, C; Rocha, M; Salazar, JD; Víctor, VM | 1 |
Bruno, BJ; Cellai, I; Chidambaram, N; Cipriani, S; Comeglio, P; Filippi, S; Galli, A; Guarnieri, G; Kim, K; Maggi, M; Maseroli, E; Mello, T; Morelli, A; Papangkorn, K; Patel, MV; Rastrelli, G; Sarchielli, E; Vangara, K; Vignozzi, L | 1 |
Doros, G; Fijak, M; Gooren, L; Haider, A; Kurtz, W; Nasser, M; Saad, F; Vignozzi, L | 1 |
Giltay, EJ; Gooren, LJ; Kalinchenko, SY; Mskhalaya, GJ; Saad, F; Tishova, YA | 1 |
Erren, M; Kamischke, A; Nieschlag, E; Simoni, M; Zitzmann, M | 1 |
Bots, ML; Emmelot-Vonk, MH; Grobbee, DE; Nakhai-Pour, HR; van der Schouw, YT; Verhaar, HJ | 1 |
2 trial(s) available for testosterone undecanoate and Innate Inflammatory Response
Article | Year |
---|---|
Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
Topics: Adult; Aged; Body Mass Index; C-Reactive Protein; Humans; Hypogonadism; Inflammation; Insulin; Interleukin-10; Interleukin-6; Leptin; Lipids; Male; Metabolic Syndrome; Middle Aged; Testosterone; Tumor Necrosis Factor-alpha; Waist Circumference; Waist-Hip Ratio | 2010 |
Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; C-Reactive Protein; Double-Blind Method; Humans; Inflammation; Male; Middle Aged; Testosterone | 2007 |
4 other study(ies) available for testosterone undecanoate and Innate Inflammatory Response
Article | Year |
---|---|
Testosterone administration increases leukocyte-endothelium interactions and inflammation in transgender men.
Topics: Adult; Androgens; Cell Adhesion Molecules; Cells, Cultured; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Inflammation Mediators; Injections, Subcutaneous; Leukocytes; Male; Prospective Studies; Testosterone; Transgender Persons; Young Adult | 2021 |
Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model.
Topics: Androgens; Animals; Diet, High-Fat; Disease Models, Animal; Fibrosis; Inflammation; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Prodrugs; Rabbits; Testosterone | 2021 |
Testosterone therapy in men with Crohn's disease improves the clinical course of the disease: data from long-term observational registry study.
Topics: C-Reactive Protein; Crohn Disease; Disease Progression; Germany; Humans; Hypogonadism; Inflammation; Leukocytes; Liver; Male; Prospective Studies; Syria; Testosterone; Transaminases | 2015 |
Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men.
Topics: Adult; Androgens; Biomarkers; Contraceptive Agents, Male; Controlled Clinical Trials as Topic; Cross-Sectional Studies; Drug Synergism; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Norethindrone; Progesterone; Progesterone Congeners; Testosterone; Testosterone Congeners | 2005 |